Brian Weinstein
Stock Analyst at William Blair
(0.37)
# 3,925
Out of 4,789 analysts
10
Total ratings
28.57%
Success rate
-17.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Brian Weinstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TXG 10x Genomics | Downgrades: Market Perform | n/a | $8.67 | - | 2 | Jul 15, 2022 | |
| GKOS Glaukos | Upgrades: Outperform | n/a | $97.09 | - | 3 | Feb 3, 2022 | |
| SERA Sera Prognostics | Initiates: Outperform | n/a | $3.43 | - | 1 | Aug 9, 2021 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $0.61 | - | 1 | Nov 23, 2020 | |
| AWH Aspira Women's Health | Initiates: Outperform | n/a | $0.10 | - | 1 | Oct 30, 2020 | |
| QDEL QuidelOrtho | Upgrades: Outperform | n/a | $34.11 | - | 2 | Jul 18, 2017 |
10x Genomics
Jul 15, 2022
Downgrades: Market Perform
Price Target: n/a
Current: $8.67
Upside: -
Glaukos
Feb 3, 2022
Upgrades: Outperform
Price Target: n/a
Current: $97.09
Upside: -
Sera Prognostics
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.43
Upside: -
Biodesix
Nov 23, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.61
Upside: -
Aspira Women's Health
Oct 30, 2020
Initiates: Outperform
Price Target: n/a
Current: $0.10
Upside: -
QuidelOrtho
Jul 18, 2017
Upgrades: Outperform
Price Target: n/a
Current: $34.11
Upside: -